Predictors of long-term drug survival for infliximab in psoriasis - Université de Reims Champagne-Ardenne
Journal Articles Journal of the European Academy of Dermatology and Venereology Year : 2017

Predictors of long-term drug survival for infliximab in psoriasis

Q. Magis
  • Function : Author
D. Jullien
  • Function : Author
C. Gaudy-Marqueste
  • Function : Author
K. Baumstark
  • Function : Author
M. Viguier
  • Function : Author
Immuno-Régulation dans les Maladies Auto-Immunes Inflammatoires et le Cancer - EA 7509
H. Bachelez
F. Guibal
  • Function : Author
E. Delaporte
  • Function : Author
E. Karimova
  • Function : Author
H. Montaudié
  • Function : Author
T. Boye
  • Function : Author
F. Aubin
M. Beylot-Barry
  • Function : Author
M.-A. Richard
  • Function : Author

Domains

Human health and pathology

Arnaud Pommier  : Connect in order to contact the contributor

https://hal.univ-reims.fr/hal-03605001

Submitted on : Thursday, March 10, 2022-5:21:14 PM

Last modification on : Tuesday, June 25, 2024-4:52:03 PM

No file

Dates and versions

hal-03605001 , version 1 (10-03-2022)

Identifiers

Cite

Q. Magis, D. Jullien, C. Gaudy-Marqueste, K. Baumstark, M. Viguier, et al.. Predictors of long-term drug survival for infliximab in psoriasis. Journal of the European Academy of Dermatology and Venereology, 2017, 31 (1), pp.96-101. ⟨10.1111/jdv.13747⟩. ⟨hal-03605001⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

URCA IRMAIC
2 View
0 Download

Altmetric

Share

More